Michele M Gulizia

Summary

Country: Italy

Publications

  1. ncbi request reprint Atrial tachyarrhythmia recurrence temporal patterns in bradycardia patients implanted with antitachycardia pacemakers
    Renato Ricci
    Institute of Cardiology, S Filippo Neri Hospital, Rome, Italy
    J Cardiovasc Electrophysiol 15:44-51. 2004
  2. ncbi request reprint Randomized comparison between Ramp and Burst+ atrial antitachycardia pacing therapies in patients suffering from sinus node disease and atrial fibrillation and implanted with a DDDRP device
    Michele Gulizia
    Cardiology Department, Garibaldi Nesima Hospital, Via Palermo 636, Catania 95122, Italy
    Europace 8:465-73. 2006
  3. doi request reprint A randomized study to compare ramp versus burst antitachycardia pacing therapies to treat fast ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators: the PITAGORA ICD trial
    Michele M Gulizia
    Garibaldi Nesima Hospital, Catania, Italy
    Circ Arrhythm Electrophysiol 2:146-53. 2009
  4. ncbi request reprint [Potential impact of drug-eluting stents in Sicily: results from a multicenter survey and cost-benefit analysis of drug-eluting stents versus bare metal stents]
    Michele Gulizia
    Cardiologia, Ospedale S Luigi S Currò, ARNAS Garibaldi, S Luigi S Currò, Ascoli Tomaselli, Catania
    Ital Heart J Suppl 5:630-8. 2004
  5. ncbi request reprint A randomized comparison of amiodarone and class IC antiarrhythmic drugs to treat atrial fibrillation in patients paced for sinus node disease: the Prevention Investigation and Treatment: A Group for Observation and Research on Atrial arrhythmias (PITAGORA
    Michele Gulizia
    Garibaldi Nesima Hospital, Catania, Italy
    Am Heart J 155:100-7, 107.e1. 2008
  6. ncbi request reprint Design and rationale of a randomized study to compare amiodarone and Class IC anti-arrhythmic drugs in terms of atrial fibrillation treatment efficacy in patients paced for sinus node disease: the PITAGORA trial
    Michele Gulizia
    Cardiology Department, Garibaldi Nesima Hospital, Via Palermo 636, Catania, 95122, Italy
    Europace 8:302-5. 2006
  7. ncbi request reprint [Selection criteria for patient admission to cardiac rehabilitation centers]
    Cesare Greco
    G Ital Cardiol (Rome) 12:219-29. 2011
  8. ncbi request reprint Far-field R wave oversensing in dual chamber pacemakers designed for atrial arrhythmia management: effect of pacing site and lead tip to ring distance
    Giuseppe Inama
    Institute of Cardiology, Maggiore Hospital, Crema, Italy
    Pacing Clin Electrophysiol 27:1221-30. 2004
  9. doi request reprint Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events
    Giovanni L Botto
    Cardiology Department, S Anna Hospital, Como, Italy
    J Cardiovasc Electrophysiol 20:241-8. 2009
  10. ncbi request reprint Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers
    Alessandro Capucci
    Cardiology Department, Civile Hospital, Piacenza, Italy
    J Am Coll Cardiol 46:1913-20. 2005

Detail Information

Publications19

  1. ncbi request reprint Atrial tachyarrhythmia recurrence temporal patterns in bradycardia patients implanted with antitachycardia pacemakers
    Renato Ricci
    Institute of Cardiology, S Filippo Neri Hospital, Rome, Italy
    J Cardiovasc Electrophysiol 15:44-51. 2004
    ..New-generation pacemakers allow continuous atrial tachyarrhythmia (AT) monitoring that provides accurate information about AT type, frequency, burden, and temporary evolution...
  2. ncbi request reprint Randomized comparison between Ramp and Burst+ atrial antitachycardia pacing therapies in patients suffering from sinus node disease and atrial fibrillation and implanted with a DDDRP device
    Michele Gulizia
    Cardiology Department, Garibaldi Nesima Hospital, Via Palermo 636, Catania 95122, Italy
    Europace 8:465-73. 2006
    ..The PITAGORA trial was a multi-centre, randomized, cross-over study aimed at comparing two different ATP modes for atrial tachyarrhythmia (AT) termination in patients suffering from sinus node disease (SND)...
  3. doi request reprint A randomized study to compare ramp versus burst antitachycardia pacing therapies to treat fast ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators: the PITAGORA ICD trial
    Michele M Gulizia
    Garibaldi Nesima Hospital, Catania, Italy
    Circ Arrhythm Electrophysiol 2:146-53. 2009
    ....
  4. ncbi request reprint [Potential impact of drug-eluting stents in Sicily: results from a multicenter survey and cost-benefit analysis of drug-eluting stents versus bare metal stents]
    Michele Gulizia
    Cardiologia, Ospedale S Luigi S Currò, ARNAS Garibaldi, S Luigi S Currò, Ascoli Tomaselli, Catania
    Ital Heart J Suppl 5:630-8. 2004
    ..Since their cost is considerably higher than that of BMS, the study assessed the economic impact of the adoption of this new therapy in the Sicilian clinical practice...
  5. ncbi request reprint A randomized comparison of amiodarone and class IC antiarrhythmic drugs to treat atrial fibrillation in patients paced for sinus node disease: the Prevention Investigation and Treatment: A Group for Observation and Research on Atrial arrhythmias (PITAGORA
    Michele Gulizia
    Garibaldi Nesima Hospital, Catania, Italy
    Am Heart J 155:100-7, 107.e1. 2008
    ....
  6. ncbi request reprint Design and rationale of a randomized study to compare amiodarone and Class IC anti-arrhythmic drugs in terms of atrial fibrillation treatment efficacy in patients paced for sinus node disease: the PITAGORA trial
    Michele Gulizia
    Cardiology Department, Garibaldi Nesima Hospital, Via Palermo 636, Catania, 95122, Italy
    Europace 8:302-5. 2006
    ..The PITAGORA trial has a multicentre, prospective, randomized, single blind design to compare amiodarone with Class IC AADs in patients who have an AF history and are paced for SND...
  7. ncbi request reprint [Selection criteria for patient admission to cardiac rehabilitation centers]
    Cesare Greco
    G Ital Cardiol (Rome) 12:219-29. 2011
    ..This Consensus Document represents, therefore, an important step forward in the search for continuity of care in high-risk patients during the post-acute phase...
  8. ncbi request reprint Far-field R wave oversensing in dual chamber pacemakers designed for atrial arrhythmia management: effect of pacing site and lead tip to ring distance
    Giuseppe Inama
    Institute of Cardiology, Maggiore Hospital, Crema, Italy
    Pacing Clin Electrophysiol 27:1221-30. 2004
    ..8% of patients). Compared to RAA, the CSO lead position was more frequently associated with FFRWO.TTRS < 10 mm was associated with lower risk of clinically significant FFRWO in RAA. (PACE 2004; 27:1221-1230)...
  9. doi request reprint Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events
    Giovanni L Botto
    Cardiology Department, S Anna Hospital, Como, Italy
    J Cardiovasc Electrophysiol 20:241-8. 2009
    ..The secondary objective was to compare intermittent versus continuous monitoring strategies...
  10. ncbi request reprint Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers
    Alessandro Capucci
    Cardiology Department, Civile Hospital, Piacenza, Italy
    J Am Coll Cardiol 46:1913-20. 2005
    ..The aim of our study was to evaluate arterial embolism (AE) occurrence rates and predictors in patients suffering from bradycardia and wearing a pacemaker with antitachycardia pacing therapies...
  11. ncbi request reprint Long-term reduction of atrial tachyarrhythmia recurrences in patients paced for bradycardia-tachycardia syndrome
    Luigi Padeletti
    Institute of Internal Medicine and Cardiology, University of Florence, Florence, Italy
    Heart Rhythm 2:1047-57. 2005
    ..Atrial tachyarrhythmias (AT) are considered progressive diseases. Several rhythm control therapies for treatment of AT have been proposed...
  12. ncbi request reprint Temporal variability of atrial tachyarrhythmia burden in bradycardia-tachycardia syndrome patients
    Luigi Padeletti
    Institute of Internal Medicine and Cardiology, University of Florence, Viale Morgagni 85, 50134 Florence, Italy
    Eur Heart J 26:165-72. 2005
    ..We studied AT burden variability in patients paced for sinus node disease (SND) in order to interpret currently published data appropriately and to evaluate reliable sample sizes...
  13. ncbi request reprint Duration of P-wave is associated with atrial fibrillation hospitalizations in patients with atrial fibrillation and paced for bradycardia
    Luigi Padeletti
    Institute of Internal Medicine and Cardiology, University of Florence, Viale Morgagni 85, 50134 Florence, Italy
    Pacing Clin Electrophysiol 30:961-9. 2007
    ..The patients were evaluated for the prevalence, cause, and predictors of hospitalization...
  14. ncbi request reprint Rate control in patients with pacemaker affected by brady-tachy form of sick sinus syndrome
    Giuseppe Boriani
    Institute of Cardiology, University of Bologna and Azienda Ospedaliera S Orsola Malpighi, Bologna, Italy
    Am Heart J 154:193-200. 2007
    ..In sinus node disease (SND) atrial tachyarrhythmias (ATs) may frequently occur, after implant of a pacemaker for bradycardia, and are to be managed by rate or rhythm control...
  15. ncbi request reprint [Economic impact of cardiac resynchronization therapy in patients with heart failure. Available evidence and evaluation of the CRT-Eucomed model for analysis of cost-effectiveness]
    Giovanni Fattore
    Facoltà di Economia Aziendale, Università degli Studi Parthenope, Napoli, Istituto di Pubblica Amministrazione e Sanità, e CeRGAS, Università degli Studi Bocconi, Milano
    Ital Heart J Suppl 6:796-803. 2005
    ..The model presented can be easily adapted to take into account new evidence and to calculate cost per QALY gained in regional and local contexts...
  16. ncbi request reprint Recurrent unexplained palpitations (RUP) study comparison of implantable loop recorder versus conventional diagnostic strategy
    Franco Giada
    Cardiovascular Department, Ospedale Umberto I, Mestre Venice, Venice, Italy
    J Am Coll Cardiol 49:1951-6. 2007
    ..The aim of the study was to compare the diagnostic yield and the costs of implantable loop recorder (ILR) with those of the conventional strategy in patients with unexplained palpitations...
  17. ncbi request reprint Rate-responsive pacing regulated by cardiac haemodynamics
    Gianni Gasparini
    Unita Operativa di Cardiologia, Ospedale Umberto I, Via Circonvallazione, 50, 30174 Mestre, Venezia, Italy
    Europace 7:234-41. 2005
    ..We checked whether the TVI sensor can drive the rate-responsive function of a cardiac pacemaker following changes in the inotropic regulation of the heart...
  18. ncbi request reprint Early EPS/ICD strategy in survivors of acute myocardial infarction with severe left ventricular dysfunction on optimal beta-blocker treatment. The BEta-blocker STrategy plus ICD trial
    Antonio Raviele
    Cardiology Division, Ospedale Umberto I, Via Circonvallazione, 50 30170 Mestre Venezia, Italy
    Europace 7:327-37. 2005
    ..Previous studies have shown the benefits of such a strategy only in high-risk patients late after MI...
  19. ncbi request reprint Predictors of atrial antitachycardia pacing efficacy in patients affected by brady-tachy form of sick sinus syndrome and implanted with a DDDRP device
    Giuseppe Boriani
    Institute of Cardiology, University of Bologna and Azienda Ospedaliera, S Orsola Malpighi, Bologna, Italy
    J Cardiovasc Electrophysiol 16:714-23. 2005
    ..Predictors of ATP efficacy in brady/tachy patients...